US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist
  • 3.450
  • -0.020-0.58%
Close Mar 28 16:00 ET
  • 3.450
  • 0.0000.00%
Post 16:03 ET
237.91MMarket Cap-11896P/E (TTM)

Trevi Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
13.43%33.92M
34.19%8.93M
7.61%9.05M
7.19%8.38M
7.66%7.56M
-7.91%29.91M
-19.53%6.66M
20.99%8.41M
-14.69%7.82M
-13.15%7.03M
Selling and administrative expenses
1.66%10.24M
3.21%2.42M
3.26%2.72M
-6.51%2.54M
7.69%2.56M
6.12%10.07M
11.75%2.34M
18.26%2.64M
1.80%2.72M
-4.80%2.38M
-General and administrative expense
1.66%10.24M
3.21%2.42M
3.26%2.72M
-6.51%2.54M
7.69%2.56M
6.12%10.07M
11.75%2.34M
18.26%2.64M
1.80%2.72M
-4.80%2.38M
Research and development costs
19.41%23.68M
50.98%6.52M
9.60%6.32M
14.48%5.84M
7.64%5M
-13.71%19.83M
-30.13%4.32M
22.28%5.77M
-21.47%5.1M
-16.89%4.65M
Operating profit
-13.43%-33.92M
-34.19%-8.93M
-7.61%-9.05M
-7.19%-8.38M
-7.66%-7.56M
7.91%-29.91M
19.53%-6.66M
-20.99%-8.41M
14.69%-7.82M
13.15%-7.03M
Net non-operating interest income expense
655.11%4.36M
34.40%1.13M
793.94%1.18M
1,156.00%1.06M
432.21%990K
148.41%577K
375.49%843K
143.85%132K
65.99%-100K
-2.41%-298K
Non-operating interest income
172.87%4.75M
1.79%1.14M
179.01%1.18M
518.97%1.21M
30,425.00%1.22M
17,300.00%1.74M
37,133.33%1.12M
21,100.00%424K
9,650.00%195K
33.33%4K
Non-operating interest expense
-66.38%391K
-98.54%4K
-98.97%3K
-48.81%151K
-23.51%231K
-3.24%1.16M
-11.33%274K
-3.63%292K
-0.34%295K
2.72%302K
Other net income (expense)
230.28%469K
-101.04%-3K
154K
212.50%153K
1,600.00%165K
148.46%142K
445.28%289K
59.40%-136K
-83.33%-11K
Gain on sale of security
----
----
----
----
----
-279.27%-147K
--0
----
-440.00%-136K
-83.33%-11K
Other non- operating income (expenses)
62.28%469K
---3K
--154K
--153K
--165K
177.07%289K
----
----
----
----
Income before tax
0.31%-29.1M
-41.23%-7.8M
6.79%-7.71M
10.94%-7.18M
12.63%-6.41M
14.05%-29.19M
35.20%-5.53M
-14.06%-8.27M
17.76%-8.06M
12.54%-7.33M
Income tax
11.11%-32K
190.00%18K
-85.71%-13K
-650.00%-30K
-40.00%-7K
-71.43%-36K
-233.33%-20K
-450.00%-7K
-100.00%-4K
66.67%-5K
Net income
0.30%-29.07M
-42.07%-7.82M
6.87%-7.7M
11.26%-7.15M
12.66%-6.4M
14.11%-29.15M
35.39%-5.51M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
Net income continuous Operations
0.30%-29.07M
-42.07%-7.82M
6.87%-7.7M
11.26%-7.15M
12.66%-6.4M
14.11%-29.15M
35.39%-5.51M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
Minority interest income
Net income attributable to the parent company
0.30%-29.07M
-42.07%-7.82M
6.87%-7.7M
11.26%-7.15M
12.66%-6.4M
14.11%-29.15M
35.39%-5.51M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.30%-29.07M
-42.07%-7.82M
6.87%-7.7M
11.26%-7.15M
12.66%-6.4M
14.11%-29.15M
35.39%-5.51M
-13.94%-8.27M
17.79%-8.05M
12.45%-7.33M
Basic earnings per share
35.56%-0.29
-33.33%-0.08
33.33%-0.08
50.00%-0.07
75.00%-0.06
69.80%-0.45
75.00%-0.06
64.71%-0.12
71.43%-0.14
44.19%-0.24
Diluted earnings per share
35.56%-0.29
-33.33%-0.08
33.33%-0.08
50.00%-0.07
75.00%-0.06
69.80%-0.45
75.00%-0.06
64.71%-0.12
71.43%-0.14
44.19%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 13.43%33.92M34.19%8.93M7.61%9.05M7.19%8.38M7.66%7.56M-7.91%29.91M-19.53%6.66M20.99%8.41M-14.69%7.82M-13.15%7.03M
Selling and administrative expenses 1.66%10.24M3.21%2.42M3.26%2.72M-6.51%2.54M7.69%2.56M6.12%10.07M11.75%2.34M18.26%2.64M1.80%2.72M-4.80%2.38M
-General and administrative expense 1.66%10.24M3.21%2.42M3.26%2.72M-6.51%2.54M7.69%2.56M6.12%10.07M11.75%2.34M18.26%2.64M1.80%2.72M-4.80%2.38M
Research and development costs 19.41%23.68M50.98%6.52M9.60%6.32M14.48%5.84M7.64%5M-13.71%19.83M-30.13%4.32M22.28%5.77M-21.47%5.1M-16.89%4.65M
Operating profit -13.43%-33.92M-34.19%-8.93M-7.61%-9.05M-7.19%-8.38M-7.66%-7.56M7.91%-29.91M19.53%-6.66M-20.99%-8.41M14.69%-7.82M13.15%-7.03M
Net non-operating interest income expense 655.11%4.36M34.40%1.13M793.94%1.18M1,156.00%1.06M432.21%990K148.41%577K375.49%843K143.85%132K65.99%-100K-2.41%-298K
Non-operating interest income 172.87%4.75M1.79%1.14M179.01%1.18M518.97%1.21M30,425.00%1.22M17,300.00%1.74M37,133.33%1.12M21,100.00%424K9,650.00%195K33.33%4K
Non-operating interest expense -66.38%391K-98.54%4K-98.97%3K-48.81%151K-23.51%231K-3.24%1.16M-11.33%274K-3.63%292K-0.34%295K2.72%302K
Other net income (expense) 230.28%469K-101.04%-3K154K212.50%153K1,600.00%165K148.46%142K445.28%289K59.40%-136K-83.33%-11K
Gain on sale of security ---------------------279.27%-147K--0-----440.00%-136K-83.33%-11K
Other non- operating income (expenses) 62.28%469K---3K--154K--153K--165K177.07%289K----------------
Income before tax 0.31%-29.1M-41.23%-7.8M6.79%-7.71M10.94%-7.18M12.63%-6.41M14.05%-29.19M35.20%-5.53M-14.06%-8.27M17.76%-8.06M12.54%-7.33M
Income tax 11.11%-32K190.00%18K-85.71%-13K-650.00%-30K-40.00%-7K-71.43%-36K-233.33%-20K-450.00%-7K-100.00%-4K66.67%-5K
Net income 0.30%-29.07M-42.07%-7.82M6.87%-7.7M11.26%-7.15M12.66%-6.4M14.11%-29.15M35.39%-5.51M-13.94%-8.27M17.79%-8.05M12.45%-7.33M
Net income continuous Operations 0.30%-29.07M-42.07%-7.82M6.87%-7.7M11.26%-7.15M12.66%-6.4M14.11%-29.15M35.39%-5.51M-13.94%-8.27M17.79%-8.05M12.45%-7.33M
Minority interest income
Net income attributable to the parent company 0.30%-29.07M-42.07%-7.82M6.87%-7.7M11.26%-7.15M12.66%-6.4M14.11%-29.15M35.39%-5.51M-13.94%-8.27M17.79%-8.05M12.45%-7.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.30%-29.07M-42.07%-7.82M6.87%-7.7M11.26%-7.15M12.66%-6.4M14.11%-29.15M35.39%-5.51M-13.94%-8.27M17.79%-8.05M12.45%-7.33M
Basic earnings per share 35.56%-0.29-33.33%-0.0833.33%-0.0850.00%-0.0775.00%-0.0669.80%-0.4575.00%-0.0664.71%-0.1271.43%-0.1444.19%-0.24
Diluted earnings per share 35.56%-0.29-33.33%-0.0833.33%-0.0850.00%-0.0775.00%-0.0669.80%-0.4575.00%-0.0664.71%-0.1271.43%-0.1444.19%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg